DDR1 and neoplasm: In addition, of five DDR1 isoforms, two are kinase‐deficient receptors for missing lacking kinase domain or kinase inactive (Kothiwale et al., 2015), which may contribute to the inefficient tumor suppression ability of small molecular inhibitors targeting kinase domain of DDR1.